CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870419387
- Phone
- 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- Open-market buys, last 90 days
- $15,026
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$15,026. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 16 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-31 | LEE WILLIS C CEO | Purchase | +100,000 | $0.05 | $5K | 690,167 |
| 2026-08-28 | LEE WILLIS C CEO | Purchase | +94,767 | $0.06 | $6K | 590,167 |
| 2026-08-27 | LEE WILLIS C CEO | Purchase | +50,000 | $0.05 | $3K | 495,400 |
| 2026-08-25 | LEE WILLIS C CEO | Purchase | +46,000 | $0.04 | $2K | 445,400 |
| 2025-08-29 | LEE WILLIS C CEO | Purchase | +170,000 | $0.01 | $2K | 275,400 |
| 2025-05-30 | LEE WILLIS C CEO | Purchase | +70,000 | $0.02 | $1K | 229,400 |
| 2024-09-16 | Lim Seah H. Director | Purchase | +20,000 | $0.04 | $800 | 4,606,626 |
| 2024-02-29 | LEE WILLIS C Co-President & COO | Purchase | +77,000 | $0.13 | $10K | 159,400 |
| 2024-02-28 | LEE WILLIS C Co-President & COO | Purchase | +15,000 | $0.12 | $2K | 82,400 |
| 2024-02-27 | LEE WILLIS C Co-President & COO | Purchase | +10,000 | $0.13 | $1K | 67,400 |
| 2024-02-26 | LEE WILLIS C Co-President & COO | Purchase | +13,200 | $0.12 | $2K | 57,400 |
| 2024-02-01 | Zwicker Ian Harvey Director | Grant or award · Options | +100,000 | $0.15 | $15K | 100,000 |
| 2024-02-01 | ZEN Wei Peu Director | Grant or award · Options | +100,000 | $0.15 | $15K | 100,000 |
| 2024-02-01 | Lim Seah H. Director | Grant or award · Options | +100,000 | $0.15 | $15K | 100,000 |
| 2024-02-01 | Stark Charles William CSO & EVP Clinical Development | Grant or award · Options | +200,000 | $0.15 | $30K | 200,000 |
| 2024-02-01 | Sekulich George Co-President & CCO | Grant or award · Options | +200,000 | $0.15 | $30K | 200,000 |
| 2024-02-01 | NAGASAKI YASUSHI CFO | Grant or award · Options | +200,000 | $0.15 | $30K | 200,000 |
| 2024-02-01 | LEE WILLIS C Co-President & COO | Grant or award · Options | +200,000 | $0.15 | $30K | 200,000 |
| 2023-12-20 | Lim Seah H. Director | Sale | −32,500 | $0.05 | $2K | 4,586,626 |
| 2023-12-15 | Lim Seah H. Director | Sale | −6,000 | $0.11 | $660 | 171,700 |
Page 1 of 45 · 886 trades